LENZ Therapeutics, Inc. layoffs
Yes. LENZ Therapeutics, Inc. has filed 3 SEC 8-Ks with Item 2.05 (exit or disposal costs) since 2023. The most recent, on Oct 28, 2026, described about 40 job cuts.
Check LENZ layoff riskSEC filings since 2023
- Oct 282026
LENZ Therapeutics to cut about 40 jobs
LENZ Therapeutics, Inc. (LENZ) · filed 13 days agoOn October 28, 2026, the board of directors of the Company (the "Board") approved a strategic reorganization to prioritize consumer marketing, allocate capital to maximize sales growth, and reduce operating expenses (the "Reorganization"), which included decreasing the Company’s headcount by approximately 75% to approximately 40 full-time employees.
- Aug 232023
Graphite Bio discloses a workforce reduction
Graphite Bio, Inc. (LENZ) · filed 168 weeks agoOn August 18, 2023, the Board also approved a restructuring plan (the “Plan”) to better align its workforce with the needs of its business, and to reduce the Company's operational cash burn in an effort to maximize its strategic optionality.
- Feb 222023
Graphite Bio discloses a workforce reduction
Graphite Bio, Inc. (LENZ) · filed 194 weeks agoOn February 16, 2023, the Board of Directors (the “Board”) of Graphite Bio, Inc. (the “Company”) approved a restructuring plan (the “Plan”) to reduce the Company’s operating costs and better align its workforce with the needs of its business.
Get this data via API
Pull layoff filings, risk scores, and WARN notices into your own product. Starts at $49/mo.